BEUDAMED
    93 results · 7ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters Classification: FDA Class 3 ×

    Prosthesis, Intervertebral Disc

    FDA Pre-Market Approval
    FDA Class 3 ·ACTIVL ARTIFICIAL DISC

    Prosthesis, Intervertebral Disc

    FDA Pre-Market Approval
    FDA Class 3 ·Aesculap activL Artificial Disc

    Prosthesis, Intervertebral Disc

    FDA Pre-Market Approval
    FDA Class 3 ·ACTIVL ARTIFICIAL DISC

    Prosthesis, Intervertebral Disc

    FDA Pre-Market Approval
    FDA Class 3 ·activL Artificial Disc

    Prosthesis, Intervertebral Disc

    FDA Pre-Market Approval
    FDA Class 3 ·activL Artificial Disc

    Prosthesis, Intervertebral Disc

    FDA Pre-Market Approval
    FDA Class 3 ·activeL Artificial Disc

    Prosthesis, Intervertebral Disc

    FDA Pre-Market Approval
    FDA Class 3 ·activL Artificial Disc

    Prosthesis, Intervertebral Disc

    FDA Pre-Market Approval
    FDA Class 3 ·activL Artifical Disc

    Prosthesis, Intervertebral Disc

    FDA Pre-Market Approval
    FDA Class 3 ·activL Artificial Disc

    Prosthesis, Intervertebral Disc

    FDA Pre-Market Approval
    FDA Class 3 ·ACTIVL ARTIFICIAL DISC

    Prosthesis, Intervertebral Disc

    FDA Pre-Market Approval
    FDA Class 3 ·ACTIVL ARTIFICIAL DISC

    Prosthesis, Intervertebral Disc

    FDA Pre-Market Approval
    FDA Class 3 ·ACTIVL ARTIFICIAL DISC

    Prosthesis, Intervertebral Disc

    FDA Pre-Market Approval
    FDA Class 3 ·Aesculap Implant Systems

    Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer

    FDA Pre-Market Approval
    FDA Class 3 ·HER2 CISH PHARMDX KIT

    Occluder, Patent Ductus, Arteriosus

    FDA Pre-Market Approval
    FDA Class 3 ·AMPLATZER DUCT OCCLUDER AND 180 DEGREE DELIVERY SYSTEM

    Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer

    FDA Pre-Market Approval
    FDA Class 3 ·HER2 CISH PHARMDX KIT

    Occluder, Patent Ductus, Arteriosus

    FDA Pre-Market Approval
    FDA Class 3 ·AMPLATZER DUCT OCCLUDER

    Occluder, Patent Ductus, Arteriosus

    FDA Pre-Market Approval
    FDA Class 3 ·Amplatzer Duct Occluder, Amplatzer Duct Occluder II, and Amplatzer Piccolo Occluder

    Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer

    FDA Pre-Market Approval
    FDA Class 3 ·HER2 CISH pharmDx Kit

    Occluder, Patent Ductus, Arteriosus

    FDA Pre-Market Approval
    FDA Class 3 ·AMPLATZER Duct Occluder Family (ADO, ADOII, Piccolo)